ClinicalTrials.gg
RecruitingNCT06873113Updated Jul 8, 2025

BFRT for Subacromial Pain

An interventional study of Active BFRT and Sham BFRT in Shoulder Pain, sponsored by University of Florida. Recruiting at 1 site in United States. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2025-07-08.

Sponsored by University of Florida · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started May 2025; still recruiting 1 year 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
36
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 146 studies in Shoulder Pain with a site in United States — 21 open to participants now, 28 under way, none of them phase 3. Shoulder Pain · United States.

Planned enrollment
77th of 122
36 · median 50
Started
2025
with 10 others
No phase
78 of 146
12 open now
Primary completion
2027-03
later than 15 of 27 live
Registered
137th of 146
by date

Among the 146 studies in Shoulder Pain with a site in United States, this one is the 77th largest by planned enrollment of the 122 interventional ones that give a count, is one of 11 that started in 2025, is one of 78 with no phase, reaches primary completion later than 15 of the 27 other live ones, and was the 137th registered.

Shoulder Pain

738 studies on the registry are indexed under Shoulder Pain; 168 are open to participants now.

Browse Shoulder Pain studies →

Open to participants now

21 of the 146 studies in Shoulder Pain with a site in United States are open now. Recruiting first, the newest first:

15 more — sign in →

All 21 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 90 Shoulder Pain studies recruiting now, 25 (28%) set no upper age limit and 55 (61%) stop at 75 or younger; 3 take children under 18; 15 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 146 studies in Shoulder Pain with a site in United States, or all of them as a file.
02

Study summary

The goal of this pilot clinical trial is to learn if blood flow restriction training is safe and feasible in patients with subacromial pain. The main questions the investigators aim to answer are:

  • What problems do participants with shoulder pain encounter when training with blood flow restriction?
  • Is it feasible to apply blood flow restriction training as part of a physical therapy intervention?
  • What are some preliminary effects of blood flow restriction training on the recovery of shoulder function and strength?

The investigators will compare active blood flow restriction training to sham (an inactive procedure designed to mimic the active training as closely as possible).

Participants will:

  • Visit the clinic for physical therapy visits and exercise with blood flow restriction training for up to 8 weeks
  • Visit the clinic for tests before starting the treatment, during the treatment (4 weeks), and after the end of the treatment (8 and 26 weeks).
03

Conditions studied

  • Shoulder Pain

Keywords

  • blood flow restriction training
  • BFRT
  • BFR
  • exercise
  • subacromial pain
  • rotator cuff tendinopathy
  • subacromial impingement
  • rotator cuff related shoulder pain
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Between 18 and 50 years of age
  • Unilateral pain in the anterolateral shoulder
  • Self-reported shoulder function of ≤7 (10, full function)
  • At least 90° of active shoulder elevation
  • 3 out of 5 positive tests to define subacromial pain.

Exclusion criteria

Exclusion Criteria (general):

  • history of shoulder fracture, frozen shoulder, or shoulder surgery
  • primary complaint of shoulder instability/dislocation
  • history of cardiovascular, neurologic, and pulmonary conditions that would impair the subject's ability to participate in physical therapy
  • active treatment for cancer
  • uncontrolled diabetes
  • uncontrolled high blood pressure
  • injection at the shoulder within 6 weeks
  • imaging evidence of rotator cuff tears
  • pregnancy

Exclusion criteria (Blood flow restriction training specific)

  • to BFRT (sickle cell anemia, deep vein thrombosis, peripheral circulatory diseases)
  • taking anticoagulant or antiplatelet drugs
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
36 participants (estimated)

Study arms

  • Experimental
    Active BFRT

    Device: Active BFRT · Behavioral: Strengthening Exercises with BFRT · Behavioral: Skilled Physical Therapy Care

  • Sham comparator
    Sham BFRT

    Device: Sham BFRT · Behavioral: Strengthening Exercises with BFRT · Behavioral: Skilled Physical Therapy Care

Interventions

  • DeviceActive BFRT

    The BFR device is applied unilaterally on participants involved upper extremity. The BFR device maintains 50% of participants limb occlusion pressure for the duration of each strengthening exercise.

  • DeviceSham BFRT

    The BFR device is applied unilaterally on participants involved upper extremity. The BFR device maintains a pressure of 20mmHg for the duration of each strengthening exercise.

  • BehavioralStrengthening Exercises with BFRT

    Participants perform 4 strengthening exercises while using the BFR device: seated scapular plane elevation, prone horizontal abduction, side-lying external rotation, and prone scapular plane elevation. Each exercise is performed unilaterally. Participants perform 1 set of 30 repetitions followed by 3 sets of 15 repetitions (4 total sets, 75 total repetitions). Participants are given 30 seconds rest between sets and 2 minutes of rest between strengthening exercises. Selected resistance for each strengthening exercise is equal to 20% of the participant's maximal force production as measured by handheld dynamometry. Resistance is adjusted weekly.

  • BehavioralSkilled Physical Therapy Care

    Participants perform non-strengthening interventions as part of skilled physical therapy care. Non-strengthening interventions include an upper arm ergometer for warm-up, active assisted range of motion of the shoulder, shoulder stretching, shoulder joint mobilizations, and cryotherapy. Non-strengthening interventions are prescribed at the discretion of the treating physical therapist. Participants are enrolled in physical therapy for a minimum of 4 weeks. After 4 weeks, the treating physical therapist can discharge a participant based on their progress in meeting their rehabilitation goals. Participants discharged from skilled physical therapy care will continue to complete strengthening exercises with BFRT until the end of the trial period (8 weeks).

06

What researchers measure

Primary outcomes

  1. Recruitment

    Record the number of individuals a) approached, b) screened, c) qualified, and d) willing to participate. The reasons for participants who do not qualify or refuse to participate will be recorded.

    Time frame: Monthly report from beginning to completion of recruitment (anticipated 2 years)

  2. Intervention feasibility

    The interventionist team will complete standardized notes of the intervention, which will be reviewed weekly to document adherence and protocol fidelity and for early identification of intervention deviations. Outcomes include the number of patients a) completing at least 80% of the assigned BFRT visits, b) requesting to stop BFRT within a session, c) requesting to withdraw from the intervention, and d) requesting to switch intervention arms. The last number is a proxy for patients who do not accept randomization results.

    Time frame: Weekly record from enrollment to the end of treatment at 8 weeks.

Secondary outcomes

  1. Retention

    Identify the number of dropouts and reasons impacting participation in follow-up visits.

    Time frame: Weekly record from enrollment to 26 weeks (end of the trial).

  2. Intervention safety

    Monitor the occurrance of severe adverse events and exercise-related adverse events.

    Time frame: Weekly record from enrollment to 26 weeks (end of the trial).

  3. Participants masking feasibility

    At the primary endpoint, participants will be asked to guess the treatment allocation to evaluate participant masking feasibility.

    Time frame: At 8 weeks

  4. Patient acceptability

    A guided interview using Likert scale-type and open-ended questions will be conducted to gather participant feedback on trial and intervention procedures. An electronic copy of this questionnaire will be sent to patients who withdraw/stop showing up to understand whether trial or intervention procedures impact patient retention.

    Time frame: At 8 weeks

  5. Range of motion

    The investigators will measure range of motion using an inclinometer or goniometer. The investigators will measure shoulder elevation in the scapular plane, external rotation, and internal rotation. The investigators will also measure coronal, axial, and sagittal rotation of the scapula during shoulder elevation in the scapular plane.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  6. Strength

    The investigators will measure shoulder elevation in the scapular plane and external rotation strength using a handheld dynamometer.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  7. Timed Functional Arm and Shoulder Test (TFAST)

    It includes three tasks: an internal/external rotation task (duration 30s), an outward circular motion task (duration 30s), and a gallon-lift task at the height of a standard counter (duration 30s). In each task, participants repeat movements as fast as possible.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  8. Supraspinatus and infraspinatus muscle cross-sectional area

    The investigators will use ultrasound to take pictures of the supraspinatus and infraspinatus muscles. This outcome represents a marker of hypertrophy, a potential mechanism of strengthening.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  9. Supraspinatus tendon morphology

    The investigators will use ultrasound to take pictures of the supraspinatus tendons. Established ultrasound procedures will be used to measure supraspinatus tendon thickness.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  10. Supraspinatus tendon elastography

    Ultrasound will be used to take pictures of the supraspinatus tendons. The investigators will set the ultrasound parameters to elastography, allowing non-invasive measurement of tendon stiffness and elasticity.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  11. Pennsylvania Shoulder Score (PENN)

    The PENN is a valid and reliable self-reported questionnaire for patients with shoulder pain.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  12. Global rating of change (GROC)

    The GROC is a rating scale that quantifies participants' improvement or deterioration of symptoms over time. Changes will be measured using a 15-points Likert scale (-7, a very great deal worse to 7, a very great deal better, with 0 indicating no changes).

    Time frame: At 4 weeks, 8 weeks and 6 months

  13. Patient specific functional scale (PSFS)

    The PSFS asks patients to rate their difficulty performing three activities of their choice. It is advantageous because it asks patients to select the activities rather than providing pre-selected options.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

Other outcomes

  1. Western Ontario Rotator Cuff Index (WORC)

    The WORC is a valid and reliable tool to assess quality of life in patients with shoulder pain. The tool contains a total of 21 Likert-type questions in five different domains (Physical symptoms, Sports/Recreation/Work/Lifestyle/Emotions)

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  2. Brief Pain Inventory (BPI)

    The BPI is a reliable, primary pain recovery measure used in clinical trials of patients with shoulder pain. It measures pain across three domains (average, best, and worst).

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  3. Patient Acceptable Symptoms State (PASS)

    The PASS is a rating scale that quantifies participants' satisfaction with their current level of function in the context of clinical care.

    Time frame: At 8 weeks and 6 months

  4. Pressure pain sensitivity

    The investigators will apply pressure at a constant rate using a computerized pressure algometer with a 1 cm diameter rubber tip at the shoulder and the lower limb.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  5. Quick Disability of the Arm and Shoulder (Q-DASH)

    The Q-DASH evaluates upper extremity disability while monitoring change or function over time. This assessment consists of 11 questions (3 items related to symptoms and 8 items related to functional tasks). Reliability and validity have been established for this scale.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  6. Infraspinatus tendon morphology

    The investigators will use ultrasound to take pictures of the infraspinatus tendons. Established ultrasound procedures will be used to measure infraspinatus tendon thickness.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  7. Infraspinatus tendon elastography

    Ultrasound will be used to take pictures of the infraspinatus tendons. The investigators will set the ultrasound parameters to elastography, allowing non-invasive measurement of tendon stiffness and elasticity.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

  8. Optimal Screening for Prediction of Referral and Outcome (OSPRO)

    The OSPRO is a concise, multidimensional 10-item yellow flag assessment tool that estimates 11 total questionnaire scores indicating elevated vulnerability and decreased resilience.

    Time frame: From enrollment to 4 weeks, 8 weeks and 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes

Supporting information: Study protocol, Statistical analysis plan, Clinical study report, Analytic code

Time frame: Study protocol \& statistical analysis plan: A manuscript describing the study protocol and statistical analysis plan will be submitted for publication within the first year of starting the clinical trial. Clinical study report and analytic code: Individual data and analytic code will be made available after the publication of the primary results of this trial.

Access criteria: Study protocol and statistical analysis plan: The manuscript will be published as open access. Clinical study report and analytic code: Data will be shared on NIH/NIAMS approvved data repository (i.e., Dataverse). Access will follow repository guidelines.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2025 (actual). Primary completion is estimated for Mar 2027, 22 months after the start.

Of 351 non-industry interventional studies with no phase under Shoulder Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 22 months is above that.

Counting every sponsor, half of 356 studies reached it within 11 months; a quarter within 4 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 3, 2025
First posted
Mar 12, 2025
StartActual
May 13, 2025
Primary completionEst.
Mar 31, 2027
CompletionEst.
Dec 31, 2028
Last update
Jul 8, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 8, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06873113
Responsible party
Sponsor
First posted
Mar 12, 2025
Start date
May 13, 2025
Primary completion
Mar 31, 2027 (estimated)
Completion
Dec 31, 2028 (estimated)
Last update
Jul 8, 2025

Study contacts

Federico Pozzi, PT, MA, PhD
Contact
fpozzi@phhp.ufl.edu
(352) 273-6957

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion